Explore
← New search
25 matching publication(s)
Targeting the epigenome and the integrated stress response to normalize colorectal cancer subclonal plasticity and progression.
PMID 41963303 · Cell Death Dis · 2026
L1
68/100
Single-cell protein activity analysis reveals aberrant myogenesis and IGF2-PI3K pathway dependencies in MYOD1-mutant rhabdomyosarcoma.
PMID 41758938 · Sci Adv · 2026
L1
84/100
Differential bone morphology and hypoxia activity in skeletal metastases of ER+ and ER- breast cancer.
PMID 39572705 · Commun Biol · 2024
L1
68/100
Understanding the function of Pax5 in development of docetaxel-resistant neuroendocrine-like prostate cancers.
PMID 39183332 · Cell Death Dis · 2024
L1
69/100
The manganese transporter SLC39A8 links alkaline ceramidase 1 to inflammatory bowel disease.⚑
PMID 38839750 · Nat Commun · 2024
L1
70/100
⚑
Mutually exclusive teams-like patterns of gene regulation characterize phenotypic heterogeneity along the noradrenergic-mesenchymal axis in neuroblastoma.
PMID 38230570 · Cancer Biol Ther · 2024
L1
87/100
Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling.
PMID 37958322 · Cancers (Basel) · 2023
L1
50/100
Stemness genes and miR-1247-3p expression associate with clinicopathological parameters and prognosis in lung adenocarcinoma.
PMID 37948380 · PLoS One · 2023
L1
90/100
FAM3C/ILEI protein is elevated in psoriatic lesions and triggers psoriasiform hyperproliferation in mice.
PMID 37226685 · EMBO Mol Med · 2023
L1
83/100
PD-1 blockade potentiates neoadjuvant chemotherapy in NSCLC via increasing CD127+ and KLRG1+ CD8 T cells.
PMID 37231145 · NPJ Precis Oncol · 2023
L1
40/100
Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic l
PMID 37217248 · J Immunother Cancer · 2023
L1
76/100
Emergent dynamics of underlying regulatory network links EMT and androgen receptor-dependent resistance in prostate cancer.
PMID 36851919 · Comput Struct Biotechnol J · 2023
L2
78/100
Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential.
PMID 36450752 · Nat Commun · 2022
L1
70/100
Stromal androgen signaling acts as tumor niches to drive prostatic basal epithelial progenitor-initiated oncogenesis.⚑
PMID 36323713 · Nat Commun · 2022
L1
63/100
⚑
Effect of PAIP1 on the metastatic potential and prognostic significance in oral squamous cell carcinoma.⚑
PMID 35153296 · Int J Oral Sci · 2022
L1
10/100
⚑
Epigenetic loss of heterogeneity from low to high grade localized prostate tumours.
PMID 34911933 · Nat Commun · 2021
L1
79/100
Monocarboxylate Transporter-2 Expression Restricts Tumor Growth in a Murine Model of Lung Cancer: A Multi-Omic Analysis.⚑
PMID 34638954 · Int J Mol Sci · 2021
L1
53/100
⚑
TGF-β-dependent reprogramming of amino acid metabolism induces epithelial-mesenchymal transition in non-small cell lung cancers.
PMID 34168290 · Commun Biol · 2021
L1
85/100
Mammary cell gene expression atlas links epithelial cell remodeling events to breast carcinogenesis.
PMID 34079055 · Commun Biol · 2021
L1
96/100
Co-regulation and function of FOXM1/RHNO1 bidirectional genes in cancer.
PMID 33890574 · Elife · 2021
L1
76/100
Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia.
PMID 32581241 · Nat Commun · 2020
L1
92/100
PDGFRA defines the mesenchymal stem cell Kaposi's sarcoma progenitors by enabling KSHV oncogenesis in an angiogenic environment.
PMID 31881074 · PLoS Pathog · 2019
L1
85/100
PI3K inhibitors protect against glucocorticoid-induced skin atrophy.
PMID 30737086 · EBioMedicine · 2019
L1
76/100
Cancer-predicting transcriptomic and epigenetic signatures revealed for ulcerative colitis in patient-derived epithelial organoids.
PMID 29983891 · Oncotarget · 2018
L1
65/100
Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypes.
PMID 28446242 · Genome Med · 2017
L1
92/100